TGFB1 and pemphigus foliaceus: Given the pivotal role of TGF-β1 in PF pathophysiology [53], our research focused on targeting this growth factor to disrupt the TGF-β1 signaling cascade, thereby unveiling novel therapeutic strategies for PF management.